Transplantation-Immunology, Institute of Immunology, University Hospital Heidelberg, Heidelberg, Germany.
Department of Hematology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
Clin Exp Immunol. 2018 Aug;193(2):241-254. doi: 10.1111/cei.13142. Epub 2018 May 31.
Patients with recurrent miscarriage (RM) show up-regulated cytotoxic natural killer (NK) cells that are suspected to play a causal role in abortion. In the present study, we investigated counter-regulating inhibitory mechanisms and compared the results in RM patients with those of healthy controls (HC), patients with end-stage renal disease (ESRD) and kidney transplant recipients late post-transplant (TX). NK, NK T and T cell subsets were analysed in the peripheral blood of 31 RM, 14 female ESRD and nine female TX patients as well as 21 female HC using eight-colour fluorescence flow cytometry. Compared with HC, RM patients showed significantly higher absolute numbers of CD56 NK cells co-expressing the phenotype interferon (IFN)-γR , IL-4 , transforming growth factor (TGF)-β , IL-4 human leucocyte antigen D-related (HLA-DR) , TGF-β HLA-DR , IL-4 TGF-β , IL-4 TGF-β , IFN-γ and/or IL-10 IFN-γ (all P ≤ 0·01), more IL-17 CD56 (P = 0·028) NK cells and more CD56 CD16 NK cells co-expressing IFN-γR, IFN-γ, IL-4 and/or TGF-β (all P ≤ 0·01). When the same cell subsets were analysed in ESRD or TX patients, cytokine-producing NK cell subsets were not significantly different from those of HC. RM patients showed significantly higher absolute numbers of CD158a , CD158b , CD158a CD158e (all P < 0·05), NKG2D NKG2A , NKG2D NKG2A , NKG2D and/or NKG2A (all P ≤ 0·01) CD56 NK cells and higher CD158a , CD158b (all P < 0·05), NKG2D and/or NKG2A (all P < 0·01) CD56 CD16 NK cells than HC. In contrast, ESRD patients had normal and TX recipients had lower CD158a and NKG2D NKG2A CD56 NK cells and lower CD158a CD56 CD16 NK cells (all P < 0·05) than HC. RM patients have abnormally high circulating NK cells expressing inhibitory cytokines and inhibitory surface receptors which might contribute to the pathogenesis of RM.
复发性流产(RM)患者表现出细胞毒性自然杀伤(NK)细胞的上调,这些细胞被怀疑在流产中起因果作用。在本研究中,我们研究了抑制性调节机制,并将 RM 患者的结果与健康对照(HC)、终末期肾病(ESRD)患者和肾移植后晚期(TX)的女性患者进行了比较。使用八色荧光流式细胞术分析了 31 例 RM、14 例女性 ESRD 和 9 例女性 TX 患者以及 21 例女性 HC 的外周血中的 NK、NK T 和 T 细胞亚群。与 HC 相比,RM 患者表现出明显更高的绝对数量的同时表达表型干扰素(IFN)-γR、IL-4、转化生长因子(TGF)-β、IL-4 人类白细胞抗原相关(HLA-DR)、TGF-β HLA-DR、IL-4 TGF-β、IL-4 TGF-β、IFN-γ 和/或 IL-10 IFN-γ 的 CD56 NK 细胞(所有 P 值均≤0.01)、更多的 IL-17 CD56 NK 细胞(P=0.028)和更多的同时表达 IFN-γR、IFN-γ、IL-4 和/或 TGF-β 的 CD56 CD16 NK 细胞(所有 P 值均≤0.01)。当在 ESRD 或 TX 患者中分析相同的细胞亚群时,细胞因子产生的 NK 细胞亚群与 HC 没有显著差异。RM 患者表现出明显更高的绝对数量的 CD158a、CD158b、CD158a CD158e(所有 P 值均<0.05)、NKG2D NKG2A、NKG2D NKG2A、NKG2D 和/或 NKG2A(所有 P 值均≤0.01)CD56 NK 细胞和更高的 CD158a、CD158b(所有 P 值均<0.05)、NKG2D 和/或 NKG2A(所有 P 值均<0.01)CD56 CD16 NK 细胞比 HC。相比之下,ESRD 患者的 CD158a 和 NKG2D NKG2A CD56 NK 细胞和 CD158a CD56 CD16 NK 细胞(所有 P 值均<0.05)均低于 HC,而 TX 受体的 CD158a 和 NKG2D NKG2A CD56 NK 细胞和 CD158a CD56 CD16 NK 细胞则低于 HC。RM 患者具有异常高的循环 NK 细胞表达抑制性细胞因子和抑制性表面受体,这可能有助于 RM 的发病机制。